You have 9 free searches left this month | for more free features.

allografting

Showing 1 - 25 of 52

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Malignant Hemopathy Trial in Saint-Etienne (Blood samples)

Not yet recruiting
  • Malignant Hemopathy
  • Blood samples
  • Saint-Etienne, France
    CHU de Saint-Etienne
Feb 7, 2022

Clinical and Imaging Results of Knee Fresh Osteochondral

Unknown status
  • Osteochondral Defect
  • Fresh osteochondral allografting
  • Barcelona, Catalunya, Spain
    Hospital de la Santa Creu i Sant Pau
Feb 9, 2021

Acute Myeloid Leukemia (AML) Trial in Worldwide (standard combination chemo, decitabine)

Active, not recruiting
  • Acute Myeloid Leukemia (AML)
  • Edegem, Antwerpen, Belgium
  • +52 more
Sep 13, 2022

Hodgkin's Lymphoma Trial in Milan (histone deacetylase inhibitor (ITF2357))

Terminated
  • Hodgkin's Lymphoma
  • histone deacetylase inhibitor (ITF2357)
  • Milan, Italy
    Istituto Nazionale per lo studio e la cura dei Tumori
Jan 18, 2022

Leukemia, Acute, MDS, Myelomonocytic Leukemia, Chronic Trial (Itacitinib)

Not yet recruiting
  • Leukemia, Acute
  • +7 more
  • (no location specified)
Apr 10, 2023

Improved Methods of Cell Selection for Bone Marrow Transplant

Recruiting
  • Graft-Versus-Host Disease
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

Lymphoma, Non-Hodgkin Trial in Saint Louis (Stem cell infusion, TLI, Anti-thymocyte globulin)

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • Stem cell infusion
  • +5 more
  • Saint Louis, Missouri
    Washington University
Jan 17, 2023

Acute Myeloid Leukaemia Trial in Leipzig (Cytarabine, human stem cells)

Completed
  • Acute Myeloid Leukaemia
  • Leipzig, Germany
    University of Leipzig, Hematology
Jan 7, 2020

Peripheral Blood Stem Cell Transplantation, Hematopoietic Stem Cell Transplantation Trial run by the National Cancer Institute

Not yet recruiting
  • Peripheral Blood Stem Cell Transplantation
  • Hematopoietic Stem Cell Transplantation
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Adult Lymphoblastic Lymphoma Trial in Birmingham (Fludarabine, Total Body Irradiation)

Completed
  • Adult Lymphoblastic Lymphoma
  • Birmingham, Alabama
    UAB Bone Marrow Transplantation and Cellular Therapy Program
Aug 23, 2022

Multiple Myeloma Trial in Torino (Lenalidomide)

Unknown status
  • Multiple Myeloma
  • Torino, Italy
    A.O.U. San Giovanni Battista
Feb 11, 2020

Keloid, Keloid Scar Following Surgery Trial in Baton Rouge (Triamcinolone Injection, Triamcinolone Injection and 5-fluorouracil

Recruiting
  • Keloid
  • Keloid Scar Following Surgery
  • Triamcinolone Injection
  • Triamcinolone Injection and 5-fluorouracil injection
  • Baton Rouge, Louisiana
    Our Lady of the Lake Hospital
Sep 8, 2021

Quality and Quantity of M-PRP Cellular Content Filgrastim vs.

Recruiting
  • Healthy
  • Gulf Breeze, Florida
    Andrews Research and Education Foundation
Oct 6, 2022

Neuroblastoma Trial in Guangzhou (Anti Thymocyte Globulin, Fludarabine, Cyclophosphamide injection)

Not yet recruiting
  • Neuroblastoma
  • Anti Thymocyte Globulin
  • +10 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Jun 29, 2022

Anterior Cruciate Ligament Injury, Anterior Cruciate Ligament Reconstruction, Joint Instability Trial in Worldwide (Anterior

Recruiting
  • Anterior Cruciate Ligament Injury
  • +2 more
  • Anterior cruciate ligament reconstruction (ACLR)
  • Lateral extra-articular tenodesis (LET)
  • Redwood City, California
  • +25 more
Dec 19, 2022

Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic

Completed
  • Acute Myeloid Leukemia/Transient Myeloproliferative Disorder
  • +76 more
  • fludarabine phosphate
  • +6 more
  • Tucson, Arizona
  • +10 more
Jan 17, 2020

Relapsed Hematologic Malignancy Trial in Bergamo (donor-derived CIK cells)

Recruiting
  • Relapsed Hematologic Malignancy
  • donor-derived CIK cells
  • Bergamo, Italy
    A O Papa Giovanni XXIII
Dec 22, 2021

Evans Calcaneal Lengthening Based on Bone Grafting Material

Completed
  • Cerebral Palsy
  • Pes Planus
    • Aurora, Colorado
      Children's Hospital Colorado
    Apr 29, 2021

    Prolymphocytic Leukemia, Recurrent Adult Hodgkin Lymphoma, Recurrent Childhood Hodgkin Lymphoma Trial in Salt Lake City,

    Completed
    • Prolymphocytic Leukemia
    • +13 more
    • Autologous Hematopoietic Stem Cell Transplantation
    • +14 more
    • Salt Lake City, Utah
    • +4 more
    Jan 17, 2020

    Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Cleveland (biological, drug, procedure)

    Completed
    • Chronic Myeloproliferative Disorders
    • +5 more
    • anti-thymocyte globulin
    • +7 more
    • Cleveland, Ohio
      Ireland Cancer Center at University Hospitals Case Medical Cente
    Jul 23, 2020

    Multiple Myeloma Trial in United States (procedure, drug, behavioral)

    Completed
    • Multiple Myeloma
    • One Autologous Transplant
    • +5 more
    • Birmingham, Alabama
    • +35 more
    Oct 19, 2021

    Allogeneic Hematopoietic Stem Cell Transplantation Trial in Vandoeuvre Les Nancy (Blood Sample, Bone marrow aspiration, Blood

    Recruiting
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • Blood Sample
    • +3 more
    • Vandoeuvre Les Nancy, France
      CHRU de Nancy
    Oct 10, 2019

    HEMATOLOGIC MALIGNANCIES Trial in Torino (TOTAL LYMPHOID IRRADIATION)

    Active, not recruiting
    • HEMATOLOGIC MALIGNANCIES
    • TOTAL LYMPHOID IRRADIATION
    • Torino, Italy
      A.O.U. San Giovanni Battista
    Feb 2, 2021

    Graft-versus-host-disease, Prophylaxis Trial in Shanghai (ATG)

    Unknown status
    • Graft-versus-host-disease
    • Prophylaxis
    • Shanghai, Shanghai, China
      Shanghai First People's HOSPITAL
    Apr 13, 2019

    Leukemia Trial in Germany, Switzerland (biological, drug, procedure)

    Completed
    • Leukemia
    • recombinant interferon alfa
    • +6 more
    • Aachen, Germany
    • +65 more
    May 2, 2018